BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25823699)

  • 1. Therapeutic options for hydrating airway mucus in cystic fibrosis.
    Tildy BE; Rogers DF
    Pharmacology; 2015; 95(3-4):117-32. PubMed ID: 25823699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy.
    Kim Chiaw P; Eckford PD; Bear CE
    Essays Biochem; 2011 Sep; 50(1):233-48. PubMed ID: 21967060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.
    Dhooghe B; Haaf JB; Noel S; Leal T
    Expert Opin Investig Drugs; 2016; 25(4):423-36. PubMed ID: 26878157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
    Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
    Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties
    Morrison CB; Shaffer KM; Araba KC; Markovetz MR; Wykoff JA; Quinney NL; Hao S; Delion MF; Flen AL; Morton LC; Liao J; Hill DB; Drumm ML; O'Neal WK; Kesimer M; Gentzsch M; Ehre C
    Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34172469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.
    Danahay HL; Lilley S; Fox R; Charlton H; Sabater J; Button B; McCarthy C; Collingwood SP; Gosling M
    Am J Respir Crit Care Med; 2020 Apr; 201(8):946-954. PubMed ID: 31898911
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystic fibrosis transmembrane conductance regulator is expressed in mucin granules from Calu-3 and primary human airway epithelial cells.
    LeSimple P; Goepp J; Palmer ML; Fahrenkrug SC; O'Grady SM; Ferraro P; Robert R; Hanrahan JW
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):511-6. PubMed ID: 23742042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR.
    Moniz S; Sousa M; Moraes BJ; Mendes AI; Palma M; Barreto C; Fragata JI; Amaral MD; Matos P
    ACS Chem Biol; 2013 Feb; 8(2):432-42. PubMed ID: 23148778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological rescue of mutant CFTR protein improves the viscoelastic properties of CF mucus.
    Gianotti A; Capurro V; Scudieri P; Galietta LJ; Moran O; Zegarra-Moran O
    J Cyst Fibros; 2016 May; 15(3):295-301. PubMed ID: 26677762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
    Clunes MT; Boucher RC
    Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis.
    Reihill JA; Douglas LEJ; Martin SL
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33810137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls.
    Bell SC; De Boeck K; Amaral MD
    Pharmacol Ther; 2015 Jan; 145():19-34. PubMed ID: 24932877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Molecule Anion Carriers Correct Abnormal Airway Surface Liquid Properties in Cystic Fibrosis Airway Epithelia.
    Gianotti A; Capurro V; Delpiano L; Mielczarek M; GarcĂ­a-Valverde M; Carreira-Barral I; Ludovico A; Fiore M; Baroni D; Moran O; Quesada R; Caci E
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration.
    Clunes LA; Davies CM; Coakley RD; Aleksandrov AA; Henderson AG; Zeman KL; Worthington EN; Gentzsch M; Kreda SM; Cholon D; Bennett WD; Riordan JR; Boucher RC; Tarran R
    FASEB J; 2012 Feb; 26(2):533-45. PubMed ID: 21990373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of airway surface liquid volume by human airway epithelia.
    Boucher RC
    Pflugers Arch; 2003 Jan; 445(4):495-8. PubMed ID: 12548395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents.
    Hirsh AJ
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1445-62. PubMed ID: 12458154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epithelium as a target for therapy in cystic fibrosis.
    Thelin WR; Boucher RC
    Curr Opin Pharmacol; 2007 Jun; 7(3):290-5. PubMed ID: 17475561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.